Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases.

Y Zhu,J H Lin,H L Liao,L Verna,M B Stemerman
DOI: https://doi.org/10.1016/S0005-2760(96)00169-5
1997-01-01
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Abstract:Lysophosphatidylcholine (lyso-PC) selectively upregulates the mRNA level of intercellular adhesion molecule-1 (ICAM-1) but not that of vascular cell adhesion molecule-1 (VCAM-1) in cultured human umbilical vein endothelial cells. Transfection studies show that lyso-PC activates the ICAM-1 promoter but not the VCAM-1 promoter. Gel mobility shift assays document an increase in NF-κB binding in cells treated with lyso-PC. The increases of ICAM-1 mRNA and NF-κB binding were inhibited by the protein tyrosine kinase inhibitors, genistein and lavendustin A, but not by inhibitors for cyclic AMP-dependent protein kinases or protein kinase C. Our results suggest that lyso-PC induces ICAM-1 expression most likely by activating NF-κB, and that the effect appears to be protein tyrosine kinase-dependent.
What problem does this paper attempt to address?